Renhuang to Set Ginseng Standards for China
Renhuang Pharmaceuticals Inc. (Harbin, China) says that China’s State Food & Drug Administration has asked the company to help establish standards for the production of Siberian ginseng (Eleutherococcus senticosus) tablets in China.
Renhuang is a supplier of Chinese medicinal botanical products, including Siberian ginseng. The company says that through an agreement with Dongfanghong Forestry Bureau, it controls 70% of the natural supply of Siberian ginseng in China.
The guidelines that Renhuang will develop will apply to all Chinese producers of Siberian ginseng medicinal products.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
